📈 After adjustment for patient severity of illness, the maximal cumulative and individual dosing of vasopressors in critically ill patients with shock varied between ICUs. There was no clear dosing above which survival to hospital discharge was impossible.
journals.lww.com/anesthesia-a...
Bref, ARRETEZ DE PRESCRIRE CETTE CHIASSE EN BARQUETTE NOMMEE TAMIFLU
@rhazelovitch.bsky.social
#CCR26 REMAP-CAP has been presented at our meeting a few times, and its always a pleasure to host the team and their results https://www.remapcap.org/
Today's presentation focusses on antiviral use in the influenza domain: Oseltamivir (5 / 10 days) vs. no antiviral
Jaw-dropping results from REMAP-CAP- oseltamivir domain today. I believe this is the first randomised evidence for oseltamivir in the critically unwell. No evidence of benefit and 98% probability of harm 🤯🤯🤯
#CCR26
It did not take atomic weapons to make man want peace. But the atomic bomb was the turn of the screw. The atomic bomb made the prospect of future war unendurable. It has led us up those last few steps to the mountain pass; and beyond there is a different country.
- Robert Oppenheimer
Happening now: REMAP-CAP (Oseltamivir for influenza) results presentation 📣
Join the #CCR26 livestream: criticalcarereviews.com
If we can't get studies to answer even "basic questions" (like ICU fluids). No way can an LLM use subsets of the lit to answer more complex questions.
TL;DR- OpenEvidence is pitching itself to healthcare organizations and physicians as the answer to thinking. #emimcc
www.nytimes.com/2026/06/08/b...
High-Dose Vitamin C in Burns
Time to Stop
🆕🔥🟢VICTORY RCT
High-dose intravenous vitamin C did not reduce mortality and organ dysfunction and may be associated with harm in patients with severe burn injury #EMIMCC
jamanetwork.com/journals/jam...
LOOK AT THIS BEAUTIFUL UNSEEN IMAGE FROM ARTEMIS II!!!
interesting piece articulating a lot of our experiences with acute #EndOfLife care
Hannah Volbecht, @wfparker.bsky.social and @iwashyna.bsky.social in @jama.com
This international randomized clinical trial evaluates the efficacy of high-dose intravenous vitamin C in reducing 28-day mortality and persistent organ dysfunction (dependence on mechanical ventilati...
New in @jama.com, an essay by Hannah Volbecht and @wfparker.bsky.social (and me) -- asking: when is it wrong or right to restrict access to ICU care that is likely physiologically effective but the team does not think will change survival to discharge?
jamanetwork.com/journals/jam...
jamanetwork.com
This Viewpoint discusses slow life support, a care strategy used when clinicians believe patient recovery is impossible but cannot negotiate full withdrawal of therapies, and provides ethical analysis...
